|
C19ORF24 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.13730002771729E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54994000000075E-05 |
| Normal-vs-Stage2 |
6.487700E-02 |
| Normal-vs-Stage3 |
2.716900E-03 |
| Normal-vs-Stage4 |
2.730300E-02 |
| Stage1-vs-Stage2 |
8.469600E-01 |
| Stage1-vs-Stage3 |
1.543580E-01 |
| Stage1-vs-Stage4 |
3.804400E-01 |
| Stage2-vs-Stage3 |
2.673800E-01 |
| Stage2-vs-Stage4 |
3.484400E-01 |
| Stage3-vs-Stage4 |
9.436000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.31699999964086E-07 |
| Normal-vs-AfricanAmerican |
3.003800E-03 |
| Normal-vs-Asian |
1.060830E-01 |
| Caucasian-vs-AfricanAmerican |
4.147200E-01 |
| Caucasian-vs-Asian |
5.484600E-01 |
| AfricanAmerican-vs-Asian |
3.082800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.09970000053517E-07 |
| Normal-vs-Female |
2.417700E-04 |
| Male-vs-Female |
3.571600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.118930E-03 |
| Normal-vs-Extreme_Weight |
8.24640000000043E-05 |
| Normal-vs-Obese |
1.982980E-03 |
| Normal-vs-Extreme_Obese |
1.863570E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.444400E-01 |
| Normal_Weight-vs-Obese |
1.860640E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.950600E-01 |
| Extreme_Weight-vs-Obese |
5.747600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.744400E-01 |
| Obese-vs-Extreme_Obese |
5.659600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.256500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.432730E-04 |
| Normal-vs-Age(61-80Yrs) |
2.28570000004868E-06 |
| Normal-vs-Age(81-100Yrs) |
7.084000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.531780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.971600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.567370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.154200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.532000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.324600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.55873999999612E-05 |
| Normal-VS-Type2 PRCC |
1.184250E-04 |
| Normal-VS-KIRP CIMP |
4.710300E-02 |
| Normal-VS-Unclassified PRCC |
1.122240E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.428570E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.544200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.272200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.445400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.998600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.630600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.82470000000313E-05 |
| Normal-vs-N1 |
8.881700E-03 |
| Normal-vs-N2 |
2.332200E-01 |
| N0-vs-N1 |
3.662800E-01 |
| N0-vs-N2 |
5.558600E-01 |
| N1-vs-N2 |
2.325200E-01 |
|
|
